Jennifer Cutler, partner at DCI Group, joins Brian Hyde to discuss the evolving landscape of mental health policy, specifically focusing on the role of psychedelics. They delve into the FDA approval process, the critical need for states to prepare their regulatory frameworks for patient access, and common misconceptions surrounding psychedelic-assisted therapy. Cutler highlights the bipartisan support for these innovative treatments, particularly for veterans, and identifies leading states in this legislative push.

Reinier Schuur, a policy analyst at the Center for Modern Health, explains the complexities and impact of Section 6001 of the Affordable Care Act (ACA), particularly concerning physician-owned hospitals. This section, enacted in 2010 due to lobbying by the American Hospital Association, prohibits new physician-owned hospitals from receiving Medicare reimbursement, effectively creating a significant barrier to their establishment and growth.

Schuur delves into the historical arguments for this prohibition, such as concerns about self-referral.

In this episode, Brian Hyde interviews Chris Snyder, a Hyatt Professor of Economics at Dartmouth College and co-director of the Market Shaping Accelerator. They delve into the concept of repurposed drugs, particularly generics, and the economic disincentives that lead to missed opportunities for new treatments. Snyder explains how the Market Shaping Accelerator uses "pull funding" to incentivize innovation in areas with high social benefit but low commercial viability, highlighting their proposal to the FDA to boost generic drug repurposing. The conversation covers the challenges of innovation, intellectual property, and the potential for significant social good through strategic market interventions.

McKenzie Richards of the Cicero Institute explains how federal WIC contracting rules have unintentionally created a geographic monopoly in the infant formula market. She details how these rigid single-supplier mandates stifle competition, compromise supply chain resilience, and limit healthy options for low-income families. Richards also proposes legislative pathways for states to restore competition through split contracts and voucher programs.

Ross Marchand of the Taxpayers Protection Alliance discusses the regulatory push in Washington State to restrict and potentially ban PTFE (Teflon) cookware. He explains how these non-scientific mandates increase consumer costs and why these state-level policies often serve as a blueprint for federal overreach.

David Dayen, executive editor of the American Prospect and co-host of the Organized Money Podcast, joins the show to discuss the outsized influence and unchecked power of the health insurance industry. Dayen explains how a handful of health insurance giants have transformed into comprehensive health conglomerates, vertically integrating to control every aspect from insurance to pharmacy benefits management and direct patient care. This consolidation creates significant conflicts of interest, allowing these companies to

Dr. Colleen Smith, an emergency medicine doctor and clinical policy analyst for the Center for Modern Health, returns to the podcast to discuss the No Surprise Act. Initially designed to protect patients from unexpected medical bills, the act has created new complexities in the healthcare system.

Dr. Smith explains how the law intended to shift billing disputes from patients to insurers and providers, but has instead led to a "snowballing mess" of disputes, high claims, and rising insurance premiums. She also delves into the broader issue of opaque healthcare pricing, the disconnect between cost and price, and advocates for a market-driven approach where patients have more direct control over their healthcare spending choices to foster innovation and affordability.